AMD: Analysts Call For Q2 Revenues Of $6.55 Billion

Advanced Micro Devices (NASDAQ: AMD) will be reporting its second quarter financial results today after market close. Analysts have a consensus $128.11 12-month price target on the company, via a total of 42 analysts, with nine analysts having strong buy ratings.

19 analysts meanwhile have buy ratings, 13 analysts have hold ratings and a single analyst has a sell rating on the stock. The street high comes from Elazar Advisors with a $230 price target, and the lowest target sits at $85.

26 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 26 analysts is $6.55 billion; this number has been revised upwards since the start of the year. The highest revenue estimate is $6.7 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently only 4 analysts who have second-quarter EBITDA estimates. The mean is currently $2.1 billion. The estimate has been revised lower since the start of the year. Street high is a $2.1 billion EBITDA estimate, and the lowest is $2 billion.

Analysts estimate that quarterly earnings per share will come in at $1.03, up from the $0.78 estimate at the start of the year. The street high estimate is $1.16, and the lowest estimate is $0.97 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Canadian Copper Set To Submit Environmental Impact Assessment In H1 2026 For Murray Brook

Related News

Haywood: Junior Mining Sector “Offers Deep Contrarian Value”

Haywood Capital Markets released its first junior exploration report for 2022. Since the company’s last...

Saturday, February 26, 2022, 01:13:00 PM

Columbia Care: Canaccord Reiterates Top Pick Following Green Leaf Medical Acquisition

Last Friday, Columbia Care Inc. (CSE: CCHW) closed their acquisition of Green Leaf Medical which...

Friday, June 18, 2021, 01:30:00 PM

Lundin Mining: BMO Lowers Targets, Rating Based On Expected Lackluster News Flow

On August 19, BMO Capital Markets lowered their 12-month price target on Lundin Mining Corporation...

Friday, August 20, 2021, 11:21:00 AM

Canaccord Lowers Aurora Cannabis Price Target To $5 Following Q2 Earnings

On February 10th, Aurora Cannabis (TSX: ACB) reported its fiscal second quarter 2022 results. The...

Sunday, February 13, 2022, 05:16:00 PM

Jushi Holdings: Canaccord Raises Price Target Following Virginia News

On Saturday, both the Virginia House and Senate approved a recreational cannabis bill, which will...

Tuesday, March 2, 2021, 02:47:00 PM